238 related articles for article (PubMed ID: 32412097)
1. Comparison of the efficacy of electroconvulsive therapy (ECT) plus agomelatine to ECT plus placebo in treatment-resistant depression.
Lin CH; Yang WC; Chen CC; Cai WR
Acta Psychiatr Scand; 2020 Aug; 142(2):121-131. PubMed ID: 32412097
[TBL] [Abstract][Full Text] [Related]
2. The Relationship Between Depression and Pain During Acute Electroconvulsive Therapy and Follow-Up Period for Patients With Treatment-Resistant Depression.
Lin CH; Yang WC; Chan MH; Chen CC
J ECT; 2022 Sep; 38(3):192-199. PubMed ID: 35220359
[TBL] [Abstract][Full Text] [Related]
3. Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial.
Stahl SM; Fava M; Trivedi MH; Caputo A; Shah A; Post A
J Clin Psychiatry; 2010 May; 71(5):616-26. PubMed ID: 20361916
[TBL] [Abstract][Full Text] [Related]
4. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
Rasmussen KG; Mueller M; Rummans TA; Husain MM; Petrides G; Knapp RG; Fink M; Sampson SM; Bailine SH; Kellner CH
J Clin Psychiatry; 2009 Feb; 70(2):232-7. PubMed ID: 19192459
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
Zajecka J; Schatzberg A; Stahl S; Shah A; Caputo A; Post A
J Clin Psychopharmacol; 2010 Apr; 30(2):135-44. PubMed ID: 20520286
[TBL] [Abstract][Full Text] [Related]
6. Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial.
Altinay M; Karne H; Anand A
Psychopharmacol Bull; 2019 Feb; 49(1):8-16. PubMed ID: 30858635
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors related to acute electroconvulsive therapy outcome for patients with major depressive disorder.
Chen CC; Lin CH; Yang WC; Chen MC
Int Clin Psychopharmacol; 2017 May; 32(3):127-134. PubMed ID: 28177952
[TBL] [Abstract][Full Text] [Related]
8. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression.
Zhong X; He H; Zhang C; Wang Z; Jiang M; Li Q; Zhang M; Huang X
J Affect Disord; 2016 Sep; 201():124-30. PubMed ID: 27208499
[TBL] [Abstract][Full Text] [Related]
9. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
[TBL] [Abstract][Full Text] [Related]
10. Depressive Symptom Dimensions in Treatment-Resistant Major Depression and Their Modulation With Electroconvulsive Therapy.
Wade BSC; Hellemann G; Espinoza RT; Woods RP; Joshi SH; Redlich R; Jørgensen A; Abbott CC; Oedegaard KJ; McClintock SM; Oltedal L; Narr KL
J ECT; 2020 Jun; 36(2):123-129. PubMed ID: 31464814
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant and neurocognitive effects of isoflurane anesthesia versus electroconvulsive therapy in refractory depression.
Weeks HR; Tadler SC; Smith KW; Iacob E; Saccoman M; White AT; Landvatter JD; Chelune GJ; Suchy Y; Clark E; Cahalan MK; Bushnell L; Sakata D; Light AR; Light KC
PLoS One; 2013; 8(7):e69809. PubMed ID: 23922809
[TBL] [Abstract][Full Text] [Related]
12. Early improvement as a predictor of final remission in patients with treatment-resistant depression receiving electroconvulsive therapy with ketofol anesthesia.
Zheng W; He M; Gu LM; Lao GH; Wang DF; Mai JX; Wu HW; Nie S; Huang X
J Affect Disord; 2022 Aug; 310():223-227. PubMed ID: 35550826
[TBL] [Abstract][Full Text] [Related]
13. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.
Goodwin GM; Emsley R; Rembry S; Rouillon F;
J Clin Psychiatry; 2009 Aug; 70(8):1128-37. PubMed ID: 19689920
[TBL] [Abstract][Full Text] [Related]
14. Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment.
Schoeyen HK; Kessler U; Andreassen OA; Auestad BH; Bergsholm P; Malt UF; Morken G; Oedegaard KJ; Vaaler A
Am J Psychiatry; 2015 Jan; 172(1):41-51. PubMed ID: 25219389
[TBL] [Abstract][Full Text] [Related]
15. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors of Relapse After Successful Electroconvulsive Therapy for Taiwanese Patients With Major Depression.
Yang WC; Lin CH; Chen CC
J ECT; 2020 Jun; 36(2):106-110. PubMed ID: 31348115
[TBL] [Abstract][Full Text] [Related]
17. Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depression.
Zhang J; Tian H; Li J; Ji S; Chen S; Zhu J; Jiang D; Wang L; Li G; Chen M; Wang W; Lin X; Zhuo C
Psychiatry Res; 2020 May; 287():112907. PubMed ID: 32179210
[TBL] [Abstract][Full Text] [Related]
18. Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy.
Lin CH; Park C; McIntyre RS
J Affect Disord; 2019 Jun; 253():154-161. PubMed ID: 31035216
[TBL] [Abstract][Full Text] [Related]
19. Influence of adjuvant nortriptyline on the efficacy of electroconvulsive therapy: A randomized controlled trial and 1-year follow-up.
Pluijms EM; Kamperman AM; Hoogendijk WJG; van den Broek WW; Birkenhäger TK
Acta Psychiatr Scand; 2022 May; 145(5):517-528. PubMed ID: 35152416
[TBL] [Abstract][Full Text] [Related]
20. Effects of Low-Dose Ketamine on the Antidepressant Efficacy and Suicidal Ideations in Patients Undergoing Electroconvulsive Therapy.
Chen Q; Dong J; Luo J; Ren L; Min S; Hao X; Luo Q; Chen J; Li X
J ECT; 2020 Mar; 36(1):25-30. PubMed ID: 31913927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
